2022 Research Projects That Need Our Help Raising Funds For:
There are three potentially curative therapeutic approaches:
- The work of the Huda Zoghbi Lab at Baylor College of Medicine on antisense oligonucleotide drug therapy
- Anastasia Khvorova’s project at the University of Massachusetts that is developing a way to reduce levels of the MECP2 protein via small interfering RNA
- Ronald Cohn’s research at The Hospital for Sick Children in Toronto focusing on removing the duplicated gene through genome editing
Updates to Current Research
In late 2010, we joined efforts with the Rett Syndrome Research Trust (RSRT) in a collaboration to find a treatment for these similar diseases. RSRT is a non-profit organization with a tax ID number. Monica at RSRT was very instrumental in establishing the MECP2 Duplication Syndrome Fund. The Fund exclusively supports projects devoted to the study and means of treatment of MECP2 Duplication Syndrome. 100% of every dollar contributed is invested in research – not a single penny goes to overhead. To date, almost $5 million has been raised for duplication projects thanks to the combined efforts of many MECP2 Duplication Syndrome families.
Important Note: When making a donation to RSRT, please make sure you clarify that the money is for “duplication” research.
To read more about our coloration with RSRT, please clink on the following link:
Huda Y. Zoghbi, M.D.
Howard Hughes Medical Institute
Baylor College of Medicine
One Baylor Plaza T807
Houston, Texas 77030, U.S.A.
Fax: (713) 798-8728
Hilde Van Esch, M.D, PhD
Centre for Human Genetics
University Hospital Gasthuisberg
SakkuBai Naidu, M.D.
Director, Neurogenetics Unit
Kennedy Krieger Institute
707 North Broadway
Baltimore, MD 21205, U.S.A.
Fax: (443) 923-2779
Sarika U. Peters, Ph.D.
Departments of Pediatrics and Psychiatry
Vanderbilt University, Vanderbilt Kennedy Center for Research on Human Development